Stroke test company seeks to raise $9 million:
This article was originally published in Clinica
Executive Summary
Proteome Sciences is to raise £6 million ($$9.4 million) from an open one for eight offer, priced at 45p. The UK listed company, which was founded in 1984, is developing a blood test for stroke and other disorders, based on changes in protein expression. The Cobham, Surrey-based proteomics company also has in development a high specificity and sensitivity test for Creutzfeldt-Jakob disease (CJD) and other transmissable spongiform encephalopathies.